|
|
Volumn 105, Issue , 2001, Pages 1-30
|
|
Biological considerations in lung cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYTOKINE;
GROWTH PROMOTOR;
METALLOPROTEINASE;
PROTEIN P53;
TISSUE INHIBITOR OF METALLOPROTEINASE;
TUMOR PROTEIN;
ANIMAL;
BLOOD;
CELL TRANSFORMATION;
CHROMOSOME ABERRATION;
CHROMOSOME DELETION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DOMINANT GENE;
DRUG ANTAGONISM;
GENE THERAPY;
GENETIC PREDISPOSITION;
GENETICS;
HETEROZYGOSITY LOSS;
HUMAN;
HUMAN CHROMOSOME;
IMMUNE DEFICIENCY;
IMMUNOLOGY;
IMMUNOTHERAPY;
LUNG TUMOR;
METABOLISM;
METHODOLOGY;
NEOVASCULARIZATION (PATHOLOGY);
ONCOGENE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SMOKING;
TUMOR SUPPRESSOR GENE;
ULTRASTRUCTURE;
ANIMALS;
CELL TRANSFORMATION, NEOPLASTIC;
CHROMOSOME ABERRATIONS;
CHROMOSOME DELETION;
CHROMOSOMES, HUMAN;
CYTOKINES;
GENE THERAPY;
GENES, DOMINANT;
GENES, TUMOR SUPPRESSOR;
GENETIC PREDISPOSITION TO DISEASE;
GROWTH SUBSTANCES;
HUMANS;
IMMUNOLOGIC DEFICIENCY SYNDROMES;
IMMUNOTHERAPY;
LOSS OF HETEROZYGOSITY;
LUNG NEOPLASMS;
METALLOENDOPEPTIDASES;
NEOPLASM PROTEINS;
NEOVASCULARIZATION, PATHOLOGIC;
ONCOGENES;
RANDOMIZED CONTROLLED TRIALS;
SMOKING;
TISSUE INHIBITOR OF METALLOPROTEINASES;
TUMOR SUPPRESSOR PROTEIN P53;
|
|
EID: 0035234054
PISSN: 09273042
EISSN: None
Source Type: Journal
DOI: 10.1007/978-1-4615-1589-0_1 Document Type: Review |
|
Times cited : (4)
|
|
References (165)
|
